AbbVie(DE:4AB)
€266.60-1.50 (-0.56%)
DE:4AB
AbbVie earnings date
€266.60
At close:-1.50 (-0.56%)
AbbVie (4AB) Q4 2021 Earnings Report
28 Followers
DE:4AB Q4 2021 EPS Results
- Actual EPS
- EUR 2.96
- Consensus EPS
- EUR 2.94
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- EUR 2.61
DE:4AB Q4 2021 Revenue Results
- Actual Revenue
- EUR 13.33B
- Expected Revenue
- EUR 13.39B
- Beat/Miss
- Missed by -EUR 58.31M
- YoY Revenue Growth
- +7.42%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/02/2022
- Time
- Before Open
- Conference Call
- Wednesday, February 2, 2022
DE:4AB Upcoming Earnings
AbbVie's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4AB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 3.48- | 2.43 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | 3.343.42 | 1.67 | 105.38% (+1.75) | |
| Jul 31, 2026 | 2026 (Q2) | 3.233.27 | 2.66 | 22.90% (+0.61) | |
| Apr 29, 2026 | 2026 (Q1) | 2.322.37 | 2.2 | 7.72% (+0.17) | |
| Feb 04, 2026 | 2025 (Q4) | 2.382.43 | 1.93 | 25.46% (+0.49) | |
| Oct 31, 2025 | 2025 (Q3) | 1.581.67 | 2.69 | -38.00% (-1.02) | |
| Jul 31, 2025 | 2025 (Q2) | 2.582.66 | 2.37 | 12.08% (+0.29) | |
| Apr 25, 2025 | 2025 (Q1) | 2.132.20 | 2.07 | 6.49% (+0.13) | |
| Jan 31, 2025 | 2024 (Q4) | 1.891.93 | 2.5 | -22.58% (-0.56) | |
| Oct 30, 2024 | 2024 (Q3) | 2.612.69 | 2.64 | 1.69% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
